View ICR - OIRA Conclusion



0910-0776 201710-0910-008
Historical Active 201409-0910-002
HHS/FDA CDER
GFI: Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the Federal Food, Drug, and Cosmetic Act
Extension without change of a currently approved collection   No
Regular
Approved without change 12/13/2017
10/19/2017
  Inventory as of this Action Requested Previously Approved
12/31/2020 36 Months From Approved 12/31/2017
109 0 104
425 0 425
0 0 0